|
|
|
Volumn 27, Issue 3 SUPPL. 7, 2000, Pages 8-10
|
|
Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
PACLITAXEL;
ADULT;
AGED;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG HYPERSENSITIVITY;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
MAJOR CLINICAL STUDY;
NEUROTOXICITY;
NEUTROPENIA;
OVARY CARCINOMA;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PACLITAXEL;
PHILADELPHIA;
|
|
EID: 0033898119
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (22)
|
|
References (15)
|
